Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NNOX NASDAQ:SGHT NASDAQ:TLSI NASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNNOXNano-X Imaging$0.91+1.4%$1.50$0.73▼$5.26$63.61M1.241.63 million shs547,570 shsSGHTSight Sciences$5.16+5.0%$5.07$3.11▼$9.24$280.48M2.38267,805 shs6,541 shsTLSITriSalus Life Sciences$4.33+2.5%$3.88$2.20▼$7.95$265.52M0.43310,559 shs21,456 shsTMCITreace Medical Concepts$4.07+1.6%$3.88$1.17▼$7.78$263.70M1.37785,065 shs54,921 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNNOXNano-X Imaging0.00%-19.98%-17.78%-51.82%-82.77%SGHTSight Sciences0.00%-2.39%-13.71%+13.66%+40.69%TLSITriSalus Life Sciences0.00%-1.63%-10.78%-6.22%-7.46%TMCITreace Medical Concepts0.00%-6.98%-10.31%+108.33%-29.82%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNNOXNano-X Imaging$0.91+1.4%$1.50$0.73▼$5.26$63.61M1.241.63 million shs547,570 shsSGHTSight Sciences$5.16+5.0%$5.07$3.11▼$9.24$280.48M2.38267,805 shs6,541 shsTLSITriSalus Life Sciences$4.33+2.5%$3.88$2.20▼$7.95$265.52M0.43310,559 shs21,456 shsTMCITreace Medical Concepts$4.07+1.6%$3.88$1.17▼$7.78$263.70M1.37785,065 shs54,921 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNNOXNano-X Imaging0.00%-19.98%-17.78%-51.82%-82.77%SGHTSight Sciences0.00%-2.39%-13.71%+13.66%+40.69%TLSITriSalus Life Sciences0.00%-1.63%-10.78%-6.22%-7.46%TMCITreace Medical Concepts0.00%-6.98%-10.31%+108.33%-29.82%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNNOXNano-X Imaging 2.67Moderate Buy$4.00340.04% UpsideSGHTSight Sciences 2.44Hold$8.2560.04% UpsideTLSITriSalus Life Sciences 2.25Hold$7.5073.41% UpsideTMCITreace Medical Concepts 1.86Reduce$4.9722.26% UpsideCurrent Analyst Ratings BreakdownLatest NNOX, TMCI, SGHT, and TLSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2026TMCITreace Medical Concepts Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$2.00 ➝ $4.007/8/2026NNOXNano-X Imaging Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/8/2026SGHTSight Sciences CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$5.15 ➝ $6.007/7/2026NNOXNano-X Imaging Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral$5.00 ➝ $3.006/22/2026NNOXNano-X Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold6/15/2026TMCITreace Medical Concepts Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/28/2026SGHTSight Sciences CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$4.35 ➝ $5.155/13/2026TLSITriSalus Life Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/13/2026TLSITriSalus Life Sciences Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$10.00 ➝ $8.005/11/2026SGHTSight Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 7/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNNOXNano-X Imaging$13.02M4.86N/AN/A$2.01 per share0.45SGHTSight Sciences$77.36M3.63N/AN/A$1.21 per share4.26TLSITriSalus Life Sciences$45.15M5.88N/AN/A($0.68) per share-6.36TMCITreace Medical Concepts$212.69M1.24N/AN/A$1.37 per share2.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNNOXNano-X Imaging-$75.02M-$1.58N/AN/AN/A-716.44%-70.96%-62.26%8/11/2026 (Estimated)SGHTSight Sciences-$38.43M-$0.71N/AN/AN/A-46.83%-52.34%-28.49%8/5/2026 (Estimated)TLSITriSalus Life Sciences-$39.23M-$1.41N/AN/AN/A-60.85%N/A-69.91%8/6/2026 (Estimated)TMCITreace Medical Concepts-$59M-$0.97N/AN/AN/A-29.44%-67.04%-30.28%8/7/2026 (Estimated)Latest NNOX, TMCI, SGHT, and TLSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026N/ANNOXNano-X Imaging-$0.1633N/AN/AN/A$5.39 millionN/A8/7/2026Q2 2026TMCITreace Medical Concepts-$0.30N/AN/AN/A$44.02 millionN/A8/6/2026Q2 2026TLSITriSalus Life Sciences-$0.1550N/AN/AN/A$10.27 millionN/A8/5/2026Q2 2026SGHTSight Sciences-$0.15N/AN/AN/A$21.69 millionN/A6/25/2026Q1 2026NNOXNano-X ImagingN/A-$0.16N/A-$0.20N/A$4.31 million5/8/2026Q1 2026TMCITreace Medical Concepts-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million5/6/2026Q1 2026SGHTSight Sciences-$0.19-$0.24-$0.05-$0.24$18.47 million$19.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNNOXNano-X ImagingN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ATLSITriSalus Life SciencesN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNNOXNano-X ImagingN/A3.643.40SGHTSight Sciences0.685.865.48TLSITriSalus Life Sciences2.585.785.46TMCITreace Medical Concepts0.723.582.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNNOXNano-X Imaging21.49%SGHTSight Sciences55.51%TLSITriSalus Life Sciences2.58%TMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipNNOXNano-X ImagingN/ASGHTSight Sciences30.40%TLSITriSalus Life Sciences16.30%TMCITreace Medical Concepts23.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNNOXNano-X Imaging19069.59 millionN/AOptionableSGHTSight Sciences21054.41 million37.87 millionOptionableTLSITriSalus Life Sciences10661.42 million51.41 millionNot OptionableTMCITreace Medical Concepts25064.87 million49.68 millionOptionableNNOX, TMCI, SGHT, and TLSI HeadlinesRecent News About These CompaniesDid Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?July 24 at 2:24 PM | prnewswire.comTreace to Report Second Quarter 2026 Financial Results on August 7, 2026July 24 at 7:05 AM | globenewswire.comWhy Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%July 23, 2026 | aaii.comAAnalyzing Atossa Genetics (NASDAQ:ATOS) and Treace Medical Concepts (NASDAQ:TMCI)July 23, 2026 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from AnalystsJuly 22, 2026 | americanbankingnews.comTreace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst SaysJuly 18, 2026 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from BrokeragesJuly 17, 2026 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Given New $4.00 Price Target at Truist FinancialJuly 16, 2026 | marketbeat.comFinancial Comparison: Treace Medical Concepts (NASDAQ:TMCI) versus Tactile Systems Technology (NASDAQ:TCMD)July 16, 2026 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in JuneJuly 15, 2026 | marketbeat.comJohnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)July 13, 2026 | globenewswire.comTMCI Share News TodayJune 30, 2026 | uk.investing.comTreace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant SystemJune 18, 2026 | globenewswire.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 22,887 SharesJune 12, 2026 | insidertrades.comTreace to Present at the Sidoti Small Cap ConferenceJune 11, 2026 | globenewswire.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 50,000 SharesJune 2, 2026 | insidertrades.comTreace Medical Concepts Balances Growth With Earnings StrainJune 1, 2026 | tipranks.comJohn Treace Purchases 4,508 Shares of Treace Medical Concepts (NASDAQ:TMCI) StockMay 29, 2026 | insidertrades.comTreace Medical Shareholders Back Directors, Pay and AuditorMay 20, 2026 | tipranks.comTreace Medical Concepts, Inc.May 15, 2026 | edition.cnn.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 43,000 SharesMay 15, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNNOX, TMCI, SGHT, and TLSI Company DescriptionsNano-X Imaging NASDAQ:NNOX$0.91 +0.01 (+1.43%) As of 12:04 PM Eastern This is a fair market value price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.Sight Sciences NASDAQ:SGHT$5.16 +0.25 (+4.99%) As of 12:03 PM Eastern This is a fair market value price provided by Massive. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.TriSalus Life Sciences NASDAQ:TLSI$4.32 +0.11 (+2.49%) As of 12:03 PM Eastern This is a fair market value price provided by Massive. Learn more.TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.Treace Medical Concepts NASDAQ:TMCI$4.07 +0.07 (+1.63%) As of 12:03 PM Eastern This is a fair market value price provided by Massive. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD’s AI Bubble Could Burst Into Explosive Upside Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case Apple’s Earnings Setup Puts Its Record Rally and AI Patience to the Test Oil Prices Are Surging and These 4 Stocks Are Cashing In MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier Forget Tesla: These 2 Earnings Reports Reveal Where the Auto Market Is Heading AMD and Cerebras Create A New Blueprint For Hardware Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
